An epitope recognised by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodium falciparum.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  1988-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0166-6851(88)90173-9PMID 2453800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of surface and internal antigens from spontaneously releasedPlasmodium falciparum merozoites by radio-iodination and metabolic labelling

  2004cited by this paper
• Codon usage in Plasmodium falciparum.

  1988cited by this paper
• Strategies for epitope analysis using peptide synthesis.

  1987cited by this paper
• Antigenic cross reactivity between p195 and a distinct protein of 100 kDa in Plasmodium falciparum.

  1987cited by this paper
• Chromosome size polymorphisms in Plasmodium falciparum can involve deletions and are frequent in natural parasite populations.

  1986cited by this paper
• The antibody response to myoglobin--I. Systematic synthesis of myoglobin peptides reveals location and substructure of species-dependent continuous antigenic determinants.

  1986cited by this paper
• Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene.

  1986cited by this paper
• A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies.

  1986cited by this paper
• Terminal galactose residues and the antigenicity of Plasmodium falciparum glycoproteins.

  1986cited by this paper
• Plasmodium falciparum antigens synthesized by schizonts and stabilized at the merozoite surface when schizonts mature in the presence of protease inhibitors.

  1986cited by this paper
• Variation in the gene encoding a major merozoite surface antigen of the human malaria parasite Plasmodium falciparum.

  1986cited by this paper
• Recognition of a Mr 56K glycoprotein on the surface of Plasmodium falciparum merozoites by mouse monoclonal antibodies.

  1985cited by this paper
• Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum

  1985cited by this paper
• Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level.

  1985cited by this paper
• Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites

  1985cited by this paper
• Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

  1985cited by this paper
• Expression of Plasmodium falciparum surface antigens in Escherichia coli.

  1985cited by this paper
• The gene for an exported antigen of the malaria parasite Plasmodium falciparum cloned and expressed in Escherichia coli.

  1985cited by this paper
• Mechanism and control of transcription initiation in prokaryotes.

  1985cited by this paper
• The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor

  1984cited by this paper
• Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages

  1984cited by this paper
• Synthesis of merozoite proteins and glycoproteins during the schizogony of Plasmodium falciparum.

  1984cited by this paper
• Efficient isolation of genes by using antibody probes.

  1983cited by this paper
• Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites

  1983cited by this paper
• Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans.

  1983cited by this paper
• An automated assay of merozoite invasion of erythrocytes using highly synchronized Plasmodium falciparum cultures.

  1982cited by this paper
• Antigenic differences among isolates of Plasmodium falciparum demonstrated by monoclonal antibodies

  1982cited by this paper
• Characterization of antigens from erythrocytic stages of Plasmodium falciparum reacting with human immune sera.

  1981cited by this paper
• Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion.

  1981cited by this paper
• Reaction of immune sera with components of the human malarial parasite, Plasmodium falciparum.

  1981cited by this paper
• Immunization against blood-stage rodent malaria using purified parasite antigens

  1981cited by this paper
• The Structure and Evolution of the Human /?-Globin Gene Family

  1980cited by this paper
• Stage-specific proteins and glycoproteins of plasmodium falciparum: identification of antigens unique to schizonts and merozoites.

  1980cited by this paper
• The structure and evolution of the human beta-globin gene family.

  1980cited by this paper
• Plasmodium falciparum strains from Papua New Guinea: culture characteristics and drug sensitivity.

  1980cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.

  1977cited by this paper
• A freeze-dried merozoite vaccine effective against Plasmodium knowlesi malaria.

  1977cited by this paper
• Antibodies to major histocompatibility antigens produced by hybrid cell lines

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Merozoite vaccination of douroucouli monkeys against falciparum malaria.

  1977cited by this paper
• Human malaria parasites in continuous culture.

  1976cited by this paper
• CARBENOXOLONE AND GASTRIC SECRETION

  1975cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Designing a multi-epitope chimeric protein from different potential targets: A potential vaccine candidate against Plasmodium.

  2023cites this paper
• Strongyloidiasis

  2020cites this paper
• A proteomic glimpse into the effect of antimalarial drugs on Plasmodium falciparum proteome towards highlighting possible therapeutic targets.

  2020cites this paper
• PRE-binding protein of Plasmodium falciparum is a potential candidate for vaccine design and development: An in silico evaluation of the hypothesis.

  2019influential citation
• Plasmodium falciparum immunodominant IgG epitopes in subclinical malaria

  2019cites this paper
• Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative

  2019cites this paper
• Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria

  2018cites this paper
• Clinical, laboratorial and immunological aspects of severe malaria in children from Guinea-Bissau.

  2018cites this paper
• Investigating the Effects of Increasing Anti-AMA1, Anti-MSP1, and Anti-MSP2 In Preventing Malaria Incidence

  2016cites this paper
• Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens

  2015cites this paper
• Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate

  2015cites this paper
• Vaccins multi-constituants et multi-stades contre le paludisme

  2015cites this paper
• Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2

  2015cites this paper
• Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains

  2014cites this paper
• 43 kDa and 66 kDa, two blood stage antigens induce immune response in Plasmodium berghei malaria.

  2014cites this paper
• Nouveaux vaccins contre les Apicomplexa pathogènes

  2013cites this paper
• Proteomic analysis of Plasmodium falciparum schizonts reveals heparin-binding merozoite proteins.

  2013cites this paper
• Identification of a Novel and Unique Transcription Factor in the Intraerythrocytic Stage of Plasmodium falciparum

  2013cites this paper
• Protein 2 Plasmodium falciparum Merozoite Surface Intrinsically Unstructured Protein, Antigenic Characterization of an

  2012influential citation
• Antigenic Characterization of an Intrinsically Unstructured Protein, Plasmodium falciparum Merozoite Surface Protein 2

  2012influential citation
• Methodology and application of flow cytometry for investigation of human malaria parasites.

  2011cites this paper
• A Phase 1 Trial of MSP 2-C 1 , a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP 2 Formulated with Montanide H ISA 720

  2011cites this paper
• A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720

  2011cites this paper
• Recombinant protein vaccines against the asexual blood-stages of Plasmodium falciparum

  2010cites this paper
• Transactions of the Royal Society of Tropical Medicine and Hygiene

  2010cites this paper
• Population genetic analysis of large sequence polymorphisms in Plasmodium falciparum blood-stage antigens.

  2010cites this paper
• Malaria : Multiclonal infections and protective immunity

  2010cites this paper
• Strain-Transcending Fc-Dependent Killing of Plasmodium falciparum by Merozoite Surface Protein 2 Allele-Specific Human Antibodies

  2010cites this paper
• Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.

  2009cites this paper
• Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.

  2009cites this paper
• Passive transfer of Plasmodium falciparum MSP-2 pseudopeptide-induced antibodies efficiently controlled parasitemia in Plasmodium berghei-infected mice.

  2009cites this paper
• Predicción de unión de péptidos de MSA-2 y AMA-1 de Plasmodium falciparum al HLA clase II

  2009cites this paper
• CARACTERIZACIÓN FÍSICA Y MATEMÁTICA DE PÉPTIDOS DE ALTA UNIÓN DE MSA-2 APLICACIÓN DE LA TEORÍA DE LA PROBABILIDAD Y LA ENTROPÍA

  2009cites this paper
• Immune responses to polymorphic antigens and protection against severe malaria in Kenyan children

  2008cites this paper
• Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria

  2008cites this paper
• Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design.

  2008cites this paper
• Origins and evolution of antigenic diversity in malaria parasites.

  2007cites this paper
• Human genetic factors in relation to Plasmodium falciparum infection

  2007cites this paper
• Antibodies induced by Plasmodium falciparum merozoite surface antigen-2-designed pseudopeptides possess neutralizing properties of the in vitro malarial infection.

  2007cites this paper
• Distribution of Plasmodium falciparum genotypes in clinically mild and severe malaria cases in Orissa, India.

  2005cites this paper
• Localisation of internal antigens of Plasmodium falciparum using monoclonal antibodies and colloidal gold

  2004cites this paper
• Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea.

  2004cites this paper
• Identification and analysis of a novel scavenger receptor-like protein conserved in Plasmodium species

  2004cites this paper
• A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.

  2004cites this paper
• Plasmodium falciparum merozoite surface protein networks and host protein interactions

  2004cites this paper
• Human Leukocyte Antigen Class II Alleles Influence Levels of Antibodies to the Plasmodium falciparum Asexual-Stage Apical Membrane Antigen 1 but Not to Merozoite Surface Antigen 2 and Merozoite Surface Protein 1

  2004cites this paper
• Characterisation of the merozoite surface protein-2 promoter using stable and transient transfection in Plasmodium falciparum.

  2003cites this paper
• Plasmodium falciparum: limited genetic diversity of MSP-2 in isolates circulating in Brazilian endemic areas.

  2003cites this paper
• Genetic Diversity and Antigenic Polymorphism in Plasmodium falciparum: Extensive Serological Cross-Reactivity between Allelic Variants of Merozoite Surface Protein 2

  2003cites this paper
• Molecular Cloning and Sequencing of the Merozoite Surface Antigen 2 Gene from Plasmodium falciparum Strain FCC-1/HN and Expression of the Gene in Mycobacteria1

  2003cites this paper
• Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project.

  2002cites this paper
• Malaria Vaccine: Candidate Antigens, Mechanisms, Constraints and Prospects

  2002cites this paper
• Merozoite antigens involved in invasion.

  2002cites this paper
• Antibodies and Plasmodium falciparum merozoites.

  2001cites this paper
• Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum.

  2001cites this paper
• Antibody Responses to Infections with Strains ofPlasmodium falciparum Expressing Diverse Forms of Merozoite Surface Protein 2

  2001cites this paper
• Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2

  2001cites this paper
• Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.

  2001cites this paper
• Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion.

  2000cites this paper
• Molecular diversity and immunological properties of the "Plasmodium falciparum" : merozoite surface protein 2(MSP2)

  2000cites this paper
• Recombinant chimeric proteins generated from conserved regions of Plasmodium falciparum merozoite surface protein 2 generate antiparasite humoral responses in mice

  2000influential citation
• Malaria vaccines.

  1999cites this paper
• Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites

  1999cites this paper
• Mammalian cell expression of malaria merozoite surface proteins and experimental DNA and RNA immunisation.

  1999cites this paper
• Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.

  1999cites this paper
• Cloning and characterization of a new asparagine-rich protein in Plasmodium falciparum

  1999cites this paper
• Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples

  1999cites this paper
• Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.

  1999cites this paper
• Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites

  1999cites this paper
• Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.

  1999cites this paper
• Temporal Variation of the Merozoite Surface Protein-2 Gene of Plasmodium falciparum

  1998cites this paper
• Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.

  1997cites this paper
• Atypical IgG subclass antibody responses to Plasmodium falciparum asexual stage antigens.

  1997cites this paper
• Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160

  1997cites this paper
• Clinical trials of malaria vaccines: progress and prospects.

  1997cites this paper
• Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum.

  1997cites this paper
• Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2

  1997cites this paper
• Association of malaria with inactivation of alpha1,3-galactosyl transferase in catarrhines.

  1997cites this paper
• Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status

  1997cites this paper
• rhoptry-associated proteins 1 and 2 . against Plasmodium falciparum Assessment of the humoral immune response

  1997cites this paper
• Sequence diversity and molecular evolution of the merozoite surface antigen 2 of plasmodium falciparum

  1997cites this paper
• Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.

  1996cites this paper
• Chapter 2c Glycoproteins of parasites: Glycoproteins of malaria parasites

  1996cites this paper
• Chapter 2a Glycoproteins of parasites: Glycoproteins of Trypanosoma cruzi

  1996cites this paper
• A peptide derived from a B cell epitope of Plasmodium falciparum rhoptry associated protein 2 specifically raises antibodies to rhoptry associated protein 1.

  1996cites this paper
• Plasmodium falciparum: variations within the C-terminal region of merozoite surface antigen-1.

  1995cites this paper
• Immunogenicity of recombinant Plasmodium falciparum rhoptry associated proteins 1 and 2

  1995cites this paper
• Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.

  1995cites this paper
• Immune responses to the Plasmodium falciparum antigen MSP2

  1995cites this paper
• Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria

  1995cites this paper
• Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass

  1995cites this paper
• Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes.

  1995cites this paper
• Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea.

  1994cites this paper
• Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes.

  1994cites this paper
• The promise of asexual malaria vaccine development.

  1994cites this paper
• Cycle DNA sequencing with [alpha-35S]dATP demonstrates polymorphism of a surface antigen in malaria parasites from Sri Lankan patients.

  1994cites this paper
• The influence of water-miscible alcohols on the conformation of antibodies directed against a defined epitope.

  1994cites this paper
• Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.

  1994cites this paper
• Studies on Cellular Immune Responses of Peripheral Blood Mononuclear Cells from Individuals in an Endemic Rural Community to a Synthetic Plasmodium Falciparum Merozoite Antigen

  1994cites this paper
• Plasmodium falciparum genetic diversity can be characterised using the polymorphic merozoite surface antigen 2 (MSA-2) gene as a single locus marker.

  1994cites this paper